Type 2 Diabetes
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Women who experienced early menopause were 2.4 times more likely to develop diabetes.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
The annual screening could decrease negative health outcomes and may be a cost-effective way to reduce complications.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
Compared with current use of metformin + sulfonylurea, the use of thiazolidinediones + metformin was associated with an increased risk of community-acquired pneumonia.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
A high BMI is associated with an increased risk for severe liver disease, and the risk is higher in those who also have type 2 diabetes mellitus.
The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.
Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
Applying necessary lifestyle changes as well as incorporating pharmaceutical drugs will improve diabetes in patients compared to drugs alone.
A 63-year-old man with type 2 diabetes was admitted to the hospital to undergo right robotic partial nephrectomy.
Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.
Pharmacotherapy and combination therapy may be a better alternative to the ACP's diabetes treatment guidelines.
Fasting glucose is specific but not sensitive, and HbA1c is neither sensitive nor specific.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.
Intensification of therapy within 6 months of metformin monotherapy failure resulted in rapid attainment of A1c goals.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.
The once-daily injection works to improve glycemic control.
A patient with type 2 diabetes is undergoing dialysis and needs to control his HbA1c levels while fasting during Ramadan.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesityJune 01, 2016
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patientsApril 20, 2016
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
A patient with type 2 diabetes presents with elevated microalbumin levels and a recent history of elevated glucose due to bedtime snacking.
High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.